These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. New aspects in the pathogenesis of dialysis-related amyloidosis: role of beta 2-microglobulin modified with advanced glycation end products in bone and joint destruction. Miyata T; Maeda K Nephrol Dial Transplant; 1996; 11 Suppl 2():140-3. PubMed ID: 8804015 [No Abstract] [Full Text] [Related]
13. Bullous amyloidosis in a hemodialysis patient is myeloma-associated rather than hemodialysis-associated amyloidosis. Chang SL; Lai PC; Cheng CJ; Yang LC; Hong HS Amyloid; 2007 Jun; 14(2):153-6. PubMed ID: 17577689 [TBL] [Abstract][Full Text] [Related]
14. New aspects in the pathogenesis of dialysis-related amyloidosis: pathophysiology of advanced glycation end products in renal failure. Miyata T Nihon Jinzo Gakkai Shi; 1996 May; 38(5):191-7. PubMed ID: 8699608 [TBL] [Abstract][Full Text] [Related]
15. Beta-2-microglobulin-associated nodular amyloidosis of the tongue. Hirshberg A; Kaplan I; Gorsky M Int J Oral Maxillofac Surg; 1998 Jun; 27(3):226-8. PubMed ID: 9662021 [TBL] [Abstract][Full Text] [Related]
16. Cutaneous and lingual papules as a sign of beta 2 microglobulin-derived amyloidosis in a long-term hemodialysis patient. Uenotsuchi T; Imafuku S; Nagata M; Kiryu H; Morita K; Koga T; Furue M Eur J Dermatol; 2003; 13(4):393-5. PubMed ID: 12948922 [TBL] [Abstract][Full Text] [Related]